19th International Myeloma Society Annual Meeting

August 25 - 27, 2022 - Los Angeles, California

The International Myeloma Society Annual Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including:

  • Scientific Programs
  • Oral Presentations (on Basic Biology, Preclinical Trials and Clinical Studies)
  • Consensus Panels
  • Poster Presentations

Preliminary Program 

 

For information about becoming an exhibitor please contact SPARGO, Inc. at ims-exhibits@spargoinc.com

Thank you to our sponsors:
Titanium
Silver
Bronze

Practical Insights in Novel Immune Therapies in Multiple Myeloma Webinar – East Coast

November 2, 2022 - Webinar, 6:00-7:30 pm EST

Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this 90-minute webinar is for you!

This high-impact, 90-minute educational program seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.

Preliminary Agenda

Our sponsors:

Practical Insights in Novel Immune Therapies in Multiple Myeloma Webinar – West Coast

November 16, 2022 - Webinar, 6:00-7:30 pm PST

Are you a hematologist or oncologist treating patients with multiple myeloma?
If so, this 90-minute webinar is for you!

This high-impact, 90-minute educational program seeks to bridge the knowledge gap between CAR T administering centers and smaller community centers where the vast majority of oncology patients are treated, and raise awareness of novel immune based strategies including antibody drug conjugates, bispecific T cell engages, and CAR T therapies among healthcare professionals.

Preliminary Agenda

Our sponsors:

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events